COARE BIOTECHNOLOGY, INC.

Company Information
Address 800 RESEARCH PKWY
OKLAHOMA CITY, OK, 73104-3611


Information

DUNS: 963335570

# of Employees: 2


Ownership Information

Hubzone Owned: N

Socially and Economically Disadvantaged: N

Woman Owned: N



Award Charts




Award Listing

  1. Development of Monoclonal Antibodies to Treat Pancreatic Cancer

    Amount: $2,000,000.00

    Abstract Pancreatic ductal adenocarcinoma PDAC is a devastating cancer with an extremely low year survival rate even for those who are diagnosed early Novel research suggests that this may be th ...

    SBIRPhase II2016Department of Health and Human Services National Institutes of Health
  2. Development of an ADC against Pancreatic Cancer

    Amount: $225,000.00

    DESCRIPTION provided by applicant Pancreatic ductal adenocarcinoma PDAC is one of the most devastating human cancers It is the fourth leading cause of cancer related deaths in the U S with a ...

    SBIRPhase I2015Department of Health and Human Services National Institutes of Health
  3. Development of ADC to Target Tumor Stem Cells In Colorectal Cancer

    Amount: $224,950.00

    DESCRIPTION provided by applicant Colorectal cancer CRC is the third leading cause of cancer related death in the U S Although advances in CRC screening surgical therapies and medical manageme ...

    SBIRPhase I2015Department of Health and Human Services National Institutes of Health
  4. Selection-driven plant metabolites for treatment of CNS diseases

    Amount: $220,099.00

    DESCRIPTION (provided by applicant): Pancreatic ductal adenocarcinoma (PDAC) is a solid tumor and is the fourth leading cause of cancer-related death in the U.S. The 5-year survival rate of its victim ...

    SBIRPhase I2013Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government